Executive Director, Pathology – Pharmaceuticals
A leader in the development of RNA based therapeutics has engaged The Leyden Group associates to identify the company’s lead in the Pathology (Anatomic & Clinical) function within their Preclinical Safety Assessment group. The company has multiple therapeutics on the market and a deep pipeline of promising drugs across a variety of disease targets. The [...]